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Autophagy and phagocytosis are conserved cellular
functions involved in innate immunity. However, the
nature of their interactions remains unclear. We
evaluated the role of autophagy in regulating phago-
cytosis in macrophages from myeloid-specific
autophagy-related gene 7-deficient (Atg7/) mice.
Atg7/ macrophages exhibited higher bacterial up-
take when infected withMycobacterium tuberculosis
(Mtb) or with M. tuberculosis var. bovis BCG (BCG).
In addition, BCG-infected Atg7/ mice showed
increased bacterial loads and exacerbated lung in-
flammatory responses. Atg7/ macrophages had
increased expression of two class A scavenger re-
ceptors: macrophage receptor with collagenous
structure (MARCO) and macrophage scavenger re-
ceptor 1 (MSR1). The increase in scavenger recep-
tors was caused by increased activity of the nuclear
factor (erythroid-derived 2)-like 2 (NFE2L2) transcrip-
tion factor resulting from accumulated sequesto-
some 1 (SQSTM1 or p62) in Atg7/ macrophages.
These insights increase our understanding of the
host-pathogen relationship and suggest that thera-
peutic strategies should be designed to include
modulation of both phagocytosis and autophagy.
INTRODUCTION
Autophagy and phagocytosis are related cellular functions.
Autophagy is a process by which organelles and cellular proteins
are encapsulated and then delivered to lysosomes for degrada-
tion or recycling (Mizushima and Komatsu, 2011). Furthermore,
autophagy functions in diverse aspects of inflammation and im-
munity (Mizushima and Komatsu, 2011; Xu and Eissa, 2010).
Phagocytosis is also involved in mammalian defense against
infection (Stuart and Ezekowitz, 2005). In contrast to autophagy,
which is involved in removal of intracellular sources, phagocy-
tosis engulfs extracellular materials. Both pathways are stimu-
lated by pattern recognition receptor ligands (Blander andMedz-
hitov, 2004; Xu et al., 2007) and have critical roles in pathogen
capture and degradation, respectively (Xu and Eissa, 2010).ImRecent studies revealed interactions between phagosomes
formed by phagocytosis and autophagosomes formed by auto-
phagy (Gutierrez et al., 2004; Sanjuan et al., 2007; Xu et al.,
2007), including a report that suggested that modulation of auto-
phagy might affect phagocytosis (Lima et al., 2011). However,
the nature of the interactions and the underlying mechanisms
remain unknown.
Tuberculosis (TB) remains as one of the major threats to
global public health (McMurray, 2001). Macrophages are the
first line of defense against Mycobacterium tuberculosis
(Mtb), being the main host cell and killing effector (Liu and
Modlin, 2008). They phagocytose and sequester bacteria in
phagosomes, which can then fuse with lysosomes for bacterial
degradation. However, Mtb has the ability to survive and grow
inside macrophages by preventing lysosomal destruction (Gu-
tierrez et al., 2004). Autophagy stimulation can be harnessed
toward enhancing macrophage defense against Mtb (Xu
et al., 2007). However, there are several gaps in our knowl-
edge, which prevent the translation of these promising studies
into therapeutic strategies. It is not known whether there is
interaction between the regulatory mechanisms governing the
processes of phagocytosis and autophagy. In this study, we
show that autophagy modulates phagocytosis by regulating
the expression of class A scavenger receptors, revealing
mechanisms by which accumulated SQSTM1 leads to
enhanced expression of scavenger receptors. Finally, we
confirm that autophagy is required for eradication of mycobac-
teria in vivo.
RESULTS
Atg7–/– Macrophages Are More Permissive to BCG
Growth
Prior studies have shown that autophagy is critical for elimination
of mycobacteria in macrophages (Castillo et al., 2012; Gutierrez
et al., 2004; Jagannath et al., 2009; Watson et al., 2012; Xu et al.,
2007). Execution of autophagy is mediated by a ubiquitination-
like system that involves two conjugation pathways (Mizushima
and Komatsu, 2011). In the first one, autophagy gene 12
(ATG12) is activated by linkage to ATG7 and then to ATG10
before becoming covalently linked to ATG5. ATG16 binding gen-
erates an ATG5-ATG12-ATG16 complex present in the auto-
phagy isolation membrane. In the second pathway, microtu-
bule-associated protein 1 light chain 3 alpha (LC3, also known
as ATG8) is cleaved by ATG4 to leave an exposed conservedmunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc. 537
Figure 1. Enhanced Mycobacterial Uptake and Growth in Atg7–/– Macrophages
(A) Lysates of BMDMs from Atg7+/+ and Atg7/ mice were evaluated by immunoblot analysis.
(B) BMDMs were infected for 1 hr with BCG at an MOI of 10. Bacterial counts were estimated at 0, 3, 5, and 7 days by the CFU assay.
(C) BMDMs were infected with GFP-expressing H37Rv strain of Mtb (MOI 50) for 60 min. Phagocytic activity was measured by flow cytometry. Representative
side scatter (SSC) versus GFP-Mtb dot plots with the corresponding mean fluorescence intensity (MFI) are shown. Mtb uptake was also measured by
fluorescencemicroscopy at 1 hr after infection. DAPI was used to counterstain the nuclei. Scale bars represent 5 mm. Bacterial uptake was evaluated at the end of
the 1 hr infection period by determining percent of infected cells (percentage of macrophages containing at least one bacterium). Representative images are
shown.
(D–F) BMDMs were infected with GFP-expressing Mtb (MOI 50). Bacterial uptake was quantified by fluorescence microscopy (D), flow cytometry (E), and CFU
assay (F).
Data are mean ± SD, n = 3; *p < 0.05, **p < 0.001. See also Figure S1.
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Autophagy Regulates Phagocytosisglycine residue required for autophagosome formation. Cleaved
LC3 is then linked to ATG7, then to ATG3, and then to phospha-
tidylethanolamine. Lipidation of LC3 is one of the best markers
for autophagy because modified LC3 remains associated with
autophagosomes until destruction at the autolysosomal stage.
Thus, both ATG5 and ATG7 are considered key autophagy pro-
teins, although they both can play a role in other cellular func-
tions besides degradative autophagy, such as LC3-associated
phagocytosis (LAP) and restriction of viral replication (Hwang
et al., 2012; Zhao et al., 2008). During LAP, LC3 is recruited to
single-membrane phagosomes in response to infectious agents,
requiring both Atg5 and Atg7 (Lerena and Colombo, 2011; San-
juan et al., 2007).
We have generated myeloid-specific Atg7-deficient mice.
We crossed mice bearing Atg7flox/flox alleles with LysM-Cre
transgenic mice, which express Cre recombinase in a
myeloid-specific manner. We then compared Atg7flox/flox
LysM-Cre-positive mice, henceforth referred to as Atg7/538 Immunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc.mice, to Atg7flox/flox littermates, i.e., Atg7+/+. Consistent with
this conditional deletion model, bone-marrow-derived macro-
phages (BMDMs) from Atg7/ mice exhibited reduction of
ATG7, inhibition of LC3II formation, and increase in SQSTM1,
a known autophagy substrate (Figure 1A; Bjørkøy et al.,
2005). We infected BMDMs from Atg7/ and Atg7+/+ mice
with BCG and estimated bacterial colony forming units (CFU).
We found that ATG7 deficiency resulted in an impaired ability
of the cell to control infection, as evidenced by greater
numbers of viable BCG in Atg7/ macrophages (Figure 1B).
Surprisingly, we noticed that the increase of BCG in Atg7/
cells was evident in cells lysed at the 0 time point, i.e., at the
end of the 1 hr infection period. We reasoned that it would
be highly unlikely that differences in bacterial killing by the
autophagic-lysosomal system could account for the observed
increase because of the short duration of infection. Instead,
the data suggested that there might be an increased bacterial
uptake by Atg7/ macrophages.
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Autophagy Regulates PhagocytosisAtg7–/– Macrophages Showed Enhanced BCG and Mtb
Uptake
To confirm that the higher bacterial CFU counts observed in
Atg7/ macrophages at the end of the 1 hr infection period
were caused by changes in phagocytic activity, we infected
BMDMs with Mtb or BCG and evaluated bacterial uptake. To
minimize any potential role for autophagic degradation in these
assays, we evaluated uptake at 30 and 60 min of infection. Up-
take of Mtb (Figure 1) or BCG (Figures S1A–S1D available online)
was substantially higher in Atg7/ macrophages. The differ-
ences in BCG uptake between the Atg7+/+ and Atg7/ macro-
phages were abolished when phagocytosis inhibitors (4C
incubation and 10 mMcytochalasin D treatment) were used, sug-
gesting that the observed differences were due to increased
BCG internalization (Figure S1E). Finally, we evaluated BCG
phagocytosis in vivo. Atg7+/+ and Atg7/ mice were infected
intraperitoneally with 5 3 105 BCG for 2 hr and then macro-
phages were recovered by peritoneal lavage and evaluated for
BCG internalization. Results showed that Atg7/ mice had a
higher percentage of BCG-infected macrophages compared to
those from Atg7+/+ mice (Figure S1F). These results confirm
that the increased phagocytosis in Atg7/ mice is operative
in vivo and is not an in-vitro-only phenomenon.
Atg7–/– Mice Exhibited Increased Susceptibility
to Mycobacterial Infection
It has been recently shown that autophagy reduces mycobacte-
rial growth in macrophages (Gutierrez et al., 2004; Jagannath
et al., 2009; Xu et al., 2007) and in Atg5 genetically deficient
mice (Castillo et al., 2012; Watson et al., 2012). We studied the
role of autophagy in mycobacterial elimination in vivo in our
myeloid-specific Atg7/ mice. Mice were inoculated with 1 3
106 BCG intranasally and bacteriological and histopathological
changes were evaluated in lungs. Atg7/ mice were more sus-
ceptible to the infection, as evidenced by higher bacterial counts
and exacerbated inflammatory responses. We determined the
extent and cellular composition of the inflammatory infiltrate in
hematoxilin and eosin-stained lung sections. One month after
infection, Atg7/ mice had more pronounced inflammatory re-
sponses, with scattered accumulations of lymphocytes and
macrophages and perivascular and peribronchiolar cellular infil-
trates (Figures 2A and S2A). Quantification of inflammation (Fig-
ure 2B) and morphometric analysis (Figure 2C) showed that
BCG-infected Atg7/ mice had exacerbated inflammation.
Similar findings were seen inmice infected for 2 or 4months (Fig-
ures S2B–S2D). Consistent with enhanced inflammatory re-
sponses to BCG infection in Atg7/ mice, lungs showed
increased cellular counts. Analysis of T cells, helper T cells, cyto-
toxic T cells, macrophages, granulocytes, and B cells in lungs or
spleens (Figures S2E and S2F) revealed proportional increase in
all populations (Figures 2D and 2E). To evaluate bacterial
dissemination in the lungs, the number of bacteria was deter-
mined by CFU assay and by acid fast staining. With CFU assays,
we observed substantially increased bacterial counts in lungs
from Atg7/ mice at 1 month after infection (Figure 2G) and
this difference continues to increase at 4 months after infection
(Figure S2B). Ziehl-Nieelsen-stained lung sections revealed
that infected Atg7/ mice had increased numbers of bacilli
per field as well (Figure 2F). Taken together, these results indi-Imcate that mice with ATG7 deficiency in myeloid cells exhibited
increased inflammation and bacterial colonization when chal-
lenged with BCG.
Atg7–/– Macrophages Displayed Enhanced Surface
Expression of the Class A Scavenger Receptors MARCO
and MSR1
To elucidate the underlying mechanisms for enhanced bacterial
uptake in Atg7/ macrophages, we first examined whether
ATG7 deficiency modulates phagocytic receptors involved in
mycobacterial internalization. Mycobacteria are internalized
through a broad array of phagocytic receptors (Ernst, 1998).
We initially evaluated the surface expression of 22 different re-
ceptors in Atg7/ and Atg7+/+ BMDMs at baseline (Table S1).
Of these receptors, only MARCO was substantially increased
in Atg7/ macrophages (Figures 3A and 3B). These data
prompted us to investigate other scavenger receptors. We found
that Atg7/ BMDMs had increase in surface expression of
another class A scavenger receptor, namely MSR1 (Figures
3A–3D). No differences in other scavenger receptors were
observed (Table S1).
We then investigated whether MARCO surface expression
was increased in Atg7/ macrophages obtained from different
body sites. In Atg7/ mice, the surface expression of MARCO
was enhanced in macrophages from other non-bone-marrow
sources, including lung, brochoalveolar lavage, and peritoneal
cavity, whereas substantial differences in spleen could not be
detected (Figure 3E). Our data suggest that Cre expression is
reduced in spleen macrophages and thus autophagy targeting
is less efficient in these cells (Figure S3). The data above sug-
gested that the receptor increase in Atg7/macrophagesmight
be responsible for the increased BCG uptake. Prior studies have
linked MARCO to mycobacterial uptake. MARCO interacts with
the mycobacterial glicolipid trehalose dimycolate to modulate
cell activation (Bowdish et al., 2009). The ability of MARCO to
bind mycobacteria suggests an important role for MARCO in
the macrophage response to this pathogen. We confirmed that
MARCO and MSR1 were involved in BCG uptake. The phago-
cytic activity was partially reduced when MARCO or MSR1
were blocked by using a neutralizing antibody E31 against
MARCO or one of two class A scavenger receptor antagonists:
fucoidan or poly(I). (Figure S4A). These data support the asser-
tion that MARCO and MSR1 are among the receptors involved
in mycobacterial internalization by macrophages. It should be
noted, however, that the receptor diversity for mycobacteria,
accompanied by receptor cooperation, makes it difficult to
dissect the role of these individual receptors during phagocy-
tosis. Taken together, these results indicate that macrophages
deficient in ATG7 displayed higher expression of MARCO and
MSR1, which correlated with their increased phagocytic
capacity.
Lack of Atg3, Atg5, or Atg7 Enhanced Scavenger
Receptor Expression and Phagocytic Capacity
Mouse embryonic fibroblasts (MEFs) have been used as a
cellular model to evaluate autophagy role in mycobacterial
studies (Pilli et al., 2012). To confirm that the increased bacte-
rial uptake in Atg7/ cells was caused by autophagy defi-
ciency, we evaluated bacterial internalization and scavengermunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc. 539
Figure 2. Increased Susceptibility to Mycobacterial Infection in Atg7–/– Mice In Vivo
Atg7+/+ and Atg7/mice were infected with 13 106 BCG intranasally and bacteriological and histopathological changes were evaluated 1month after infection.
(A) Representative lung sections from naive and BCG-infected Atg7/ and Atg7+/+ mice are shown.
(B and C) Degree of lung inflammation was estimated (B), and the percentage of lung involved in the inflammatory response was determined by morphometric
analysis (C).
(D and E) The cellular composition of the inflammatory infiltrate in lungs (D) and spleens (E) was evaluated by flow cytometry, with conjugated antibodies against
CD3+ (T cells), CD4+CD3+ (helper T cells), CD8+CD3+ (cytotoxic T cells), F4/80 (macrophages), Lys6c (granulocytes), or B220 (B cells).
(F and G) Number of BCGbacilli in the lung was determined by counting Ziehl-Neelsen-stained bacilli per field of lung section (F) and the number of viable bacteria
was estimated by the CFU assay (G). Data expressed as Log10 CFU.
Data are mean ± SD. *p < 0.05. Scale bars represent 500 mm. See also Figure S2.
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Autophagy Regulates Phagocytosisreceptor expression in MEFs obtained from Atg3/, Atg5/,
or Atg7/ mice, compared to their wild-type counterparts (Fig-
ure 4). Atg-deficient MEFs exhibited reduction of the corre-
sponding ATG levels, inhibition of LC3II formation, and increase
of SQSTM1 (Figure 4A). Furthermore, we found that Atg3/,
Atg5/, and Atg7/ MEFs had increase in total protein, sur-
face expression and mRNA of MARCO and MSR1 (Figures
4B–4E), and increased ability to internalize BCG (Figure 4E).
These data suggest that the observed changes in scavenger
receptor expression and phagocytosis in Atg7/ cells are
autophagy dependent and not due to an autophagy-indepen-
dent role of ATG7.540 Immunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc.Atg7–/– Macrophages Exhibited Increased Phagocytosis
of Bacteria Known to Be Internalized through Class A
Scavenger Receptors
Because scavenger receptors can mediate uptake of other
bacteria, we sought to determine whether Atg7/ macro-
phages would have increased uptake of such bacteria as
well. We evaluated the uptake of S. aureus and E. coli because
both are internalized through class A scavenger receptors.
Phagocytosis of S. aureus and E. coli was measured by flow
cytometry with pHrodo-labeled bacteria. Bacteria conjugated
to pHrodo dye are nonfluorescent outside the cell or when sur-
face bound but become bright red when they are intracellular.
Figure 3. Increased Surface Expression of
Class A Scavenger Receptors MARCO and
MSR1 in Atg7–/– Macrophages
Receptor expression in BMDMs from Atg7+/+ and
Atg7/ mice was measured by flow cytometry.
MSR1 expression was measured by immunoblot
and flow cytometry with a goat polyclonal antibody
from R&D Systems. An Alexa Fluor 594 donkey
anti-goat antibody was used as secondary anti-
body for flow cytometry.
(A and B) Representative histogram (A) and quan-
titative data (B) of surface expression of MARCO
and SR-A are shown.
(C and D) Representative blot (C) and quanti-
tative analysis (D) of MSR1 expression. Antibodies
to ATG7, SQSTM1, LC3, and ACTIN were used
to confirm the phenotype. Immunoblot data
are expressed relative to intensity of the ACTIN
band and flow cytometry data are expressed
as MFI.
(E) MARCO surface expression was evaluated in
different macrophage populations.
Data are expressed as fold increase in Atg7/
relative to that of Atg7+/+ cells. Data are shown as
mean ± SD (n = 6); *p < 0.05, **p < 0.001. See also
Figure S3 and Table S1.
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Autophagy Regulates PhagocytosisAtg7/ macrophages exhibited increases E. coli and S. aureus
internalization (Figure 5). In contrast, there were no differences
in zymosan phagocytosis, which is known to be internalized via
receptors other than scavenger receptors (Figure S4B). The up-
take of latex beads remained unchanged (Figure S4B), even
though these receptors have been implicated in bead internal-
ization by alveolar macrophages (Palecanda et al., 1999; Zhou
et al., 2008). These findings support the hypothesis that the
observed increase in phagocytosis by Atg7/ macrophages
is due to enhanced surface expression of class A scavenger
receptors.
Next, we investigated whether endocytosis was altered in
Atg7/ macrophages. We tested ligands for class A scavenger
receptors (acetylated LDL, LPS, and titaniumoxide) (Figure S4C).
We also evaluated particles that are not ligands for scavenger re-
ceptors (transferrin, cholera toxin subunit B, and dextran) (Fig-
ure S4C). No differences in the endocytic capacity were
observed. These results suggest that the differences in Atg7/
cells apply only to the internalization by phagocytosis and not
to that by endocytosis. Changes in other aspects, such as lipid
membrane composition or formation of plasma membrane
microdomains, could accompany the differential scavenger re-
ceptor expression to contribute together to the increased
phagocytic capacity of Atg7/ macrophages (Stuart and Eze-
kowitz, 2005). Taken together, these results indicate that
MARCO and MSR1 are responsible for the increased uptake
observed in ATG7-deficient macrophages.Immunity 39, 537–547, SeUpregulation of MARCO and MSR1
mRNA in Atg7–/– Macrophages
We proceeded to identify the mechanism
responsible for the upregulation of
MARCO and MSR1 in Atg7/ macro-
phages. We evaluated receptor mRNAexpression in BMDMs from Atg7/ and Atg7+/+mice. We found
that mRNAs of both MARCO and MSR1 were substantially
elevated in Atg7/ cells (Figures 6A and 6B). Because MARCO
mRNA is known to be induced by LPS, we used LPS induction of
MARCO in our assays as a positive control. BMDMs from Toll-
like receptor 4 (TLR4)-, Toll-interleukin 1 receptor (TIR) domain
containing adaptor protein (TIRAP)-, TIR-domain-containing
adaptor-inducing interferon-b (TRIF)-, and p50-deficient mice
were used as negative controls (Figures S5A–S5E).
A recent study revealed thatMARCO is one of the target genes
for the nuclear factor (erythroid-derived 2)-like 2 (NFE2L2) (Har-
vey et al., 2011). The MARCO promoter was found to contain
antioxidant response elements (ARE), which are known to
mediate the effect of NFE2L2. We determined the presence of
ARE sequences in the mouse and human genomic sequence
in the 50 untranslated region of Msr1, suggesting that Msr1 is
also a potential transcriptional target for NFE2L2 (Figures S5F
and S5G). NFE2L2, also known as Nrf2, is a key transcriptional
regulator (Kensler et al., 2007). Under quiescent conditions,
NFE2L2 interacts with Kelch-like ECH-associated protein 1
(KEAP1), which continuously targets NFE2L2 for proteasomal
degradation, maintaining a low basal expression of NRF2-regu-
lated genes. However, upon recognition of oxidative and electro-
philic signals, NRF2 is released from KEAP1, escapes degrada-
tion, translocates to the nucleus, and transactivates expression
of cytoprotective genes (Harvey et al., 2011). Additional
recent evidence suggests that SQSTM1 interacts with theptember 19, 2013 ª2013 Elsevier Inc. 541
Figure 4. Increased Scavenger Receptor Expression and Bacterial Uptake in Autophagy-Deficient MEFs
MEFs of Atg3/, Atg5/, Atg7/, and their wild-type controls were evaluated.
(A) Antibodies to ATG7, ATG5, SQSTM1, LC3, and b-ACTIN were used to confirm the autophagy-deficient phenotypes.
(B) Representative blot of MSR1 and b-ACTIN expression.
(C and D) Receptor expression of MARCO and MSR1 was measured by flow cytometry. Representative histograms (C) and quantitative analyses (D) are shown.
(E) Real-time PCR was done with mRNA of MEFs and specific primers for MARCO or MSR1.
(F) MEFs were infected for 1 hr with GFP-BCG (MOI 10). Percentage of infected cells was determined by immunofluorescence.
Data are mean ± SD, n = 6, *p < 0.05, **p < 0.001.
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Autophagy Regulates PhagocytosisNFE2L2-binding site on KEAP1 and thus disrupts KEAP1 inhibi-
tory effect on NFE2L2. SQSTM1, also known as p62, is one of the
best known substrates for autophagy (Bjørkøy et al., 2005; Pan-
kiv et al., 2007). Thus, autophagy deficiency is accompanied by
accumulation of SQSTM1 (Figure 1A; Liu et al., 2012; Mizushima
and Komatsu, 2011). Based on these recent findings, we hypoth-
esized that in autophagy-deficient macrophages, accumulated
SQSTM1 interacts with KEAP1, liberating it from NFE2L2, and
then accumulation of NFE2L2 leads to upregulation of MARCO
and MSR1. To test this hypothesis, we evaluated NFE2L2
expression and activity in Atg7/ macrophages. We observed
increased NFE2L2 amounts in nuclear fractions from Atg7/
BMDMs (Figure 6C), as well as more NFE2L2 activity in Atg7/
macrophages, as evidenced by the higher ability of the active
form of NFE2L2 to bind to immobilized oligonucleotides contain-
ing the corresponding transcription factor binding site (Fig-
ure 6D). To confirm the functional consequences of increased
NFE2L2 activity in Atg7/ macrophages, we evaluated the542 Immunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc.expression of NAD(P)H dehydrogenase, quinone 1 (Nqo1) and
glutathione S-transferase mu 1 (Gstm1), known downstream
target genes for NFE2L2. NQO1 was upregulated in Atg7/
macrophages at the mRNA and protein levels (Figures 6E and
6F), supporting the conclusion of increased NFE2L2 activity
upon loss of ATG7. As a negative control, there were no substan-
tial differences between Atg7/ and Atg7+/+ macrophages in
the expression of genes that are not under NFE2L2 regulation
such as transcription factor EB (TFEB) and STIP1 homology
and U-Box containing protein 1 (Stub1) (Figure 6E). Furthermore,
the expression of MARCO and MSR1 was inhibited with SN-50,
an inhibitor that prevents NRF2 nuclear translocation. (Figures
S5H and S5I).
The data above suggested that the increase in MARCO and
MSR1 in Atg7/ macrophages is caused by accumulation of
SQSTM1 leading to enhanced NFE2L2 activation. Although
the baseline of NFE2L2 is kept low by its constant degradation,
we tested whether SQSTM1-deficient macrophages might
Figure 5. Increased Phagocytosis of S. aureus and E. coli in Atg7–/–
Macrophages
BMDMs from Atg7/ and Atg7+/+ mice were infected for 30 min or 1 hr with
pHrodo-labeled S. aureus or E. coli (MOI 10) and bacterial uptake was
measured by flow cytometry. Representative overlaid histograms (A) and
quantitative analyses (B) are shown. Data show the MFI relative to uninfected
cells (mean ± SD), n = 3; *p < 0.05, **p < 0.001. See also Figure S4.
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Autophagy Regulates Phagocytosishave even lower amounts of NFE2L2 and thus lower expres-
sion of MARCO and MSR1. To answer this question, we stud-
ied BMDMs from SQSTM1-deficient mice. Importantly, we
found that nuclear NFE2L2 levels were reduced in Sqstm1/
macrophages, and that was associated with reduction in
both mRNA and surface expression of MARCO, compared to
those in control cells (Figures S5J–S5L). Expression of mRNA
of Nqo1, an NFE2L2 target gene, was also reduced. In
contrast, the surface expression of transferrin receptor,
CD14, and TLR2, which are not under the transcriptional regu-
lation of NFE2L2, was not substantially different. These data
confirm the critical role of SQSTM1 in modulating NFE2L2
levels and scavenger receptor expression. However, the ability
to internalize BCG was not decreased in Sqstm1/ macro-
phages (Figure S5M), consistent with a recent study (Ponpuak
et al., 2010). This finding is probably due to compensatory
increased by other receptors, as previously shown (Court
et al., 2010). Taken together, these results indicate that accu-
mulation of SQSTM1 leads to increased activation of NFE2L2
and the subsequent increase in MARCO and MSR1. A model
for the mechanism of autophagy regulation of phagocytosis is
shown in Figure S6.DISCUSSION
This study shows that autophagy modulates phagocytosis. It
shows that the underlying mechanism for increased phagocy-
tosis in autophagy-deficient macrophages is through increased
scavenger receptor expression, caused by higher activation of
NFE2L2. Our study shows the physiological relevance of auto-
phagy-mediated regulation of phagocytosis in the context of
mycobacterial infection. Further, this study confirms that auto-Imphagy is important in the control of infection by mycobacteria
in vivo in ATG7-deficient mice.
This study reveals a role for autophagy as a modulator of
phagocytosis via scavenger receptors. The potential for cross
talk between autophagy and phagocytosis has been recently
suggested. The activation of both pathways requires hVPS34
PI3K kinase and can be promoted by Toll-like receptor agonists
(Gutierrez et al., 2004; Sanjuan et al., 2007; Xu et al., 2007). Our
study clearly shows that phagocytosis is enhanced in auto-
phagy-deficient macrophages. Increased uptake of mycobacte-
ria in autophagy-deficient macrophages was observed as early
as 30min after infection, making it unlikely to be explained by dif-
ferences in lysosomal degradation. Supporting this notion, our
previous ultrastructural analysis by electron microscopy showed
that at an hour after infection, most of mycobacteria can be
found inside single-membrane phagosomal compartments, not
in autophagosomes (Xu et al., 2007). Because we focused our
study on the role of ATG7 deficiency in macrophages, it remains
to be elucidated whether other Atg genes can also modulate
phagocytosis and receptor expression in these cells, as well as
the contribution of differential LC3 recruitment to phagosomes
in our experimental conditions.
It has been previously shown that autophagy is required for
mycobacterial control in macrophages (Gutierrez et al., 2004;
Xu et al., 2007). A recent study also discovered a link between
the autophagy pathway, bacterial ESX-1 system, and cytosolic
DNA-sensing pathway in the host in control of mycobacterial
infection (Watson et al., 2012). We found that defects in auto-
phagy lead to increased mycobacterial uptake in macrophages
because of enhanced availability of phagocytic receptors at the
cell surface. Thus, our study demonstrates another mechanism,
at the level of receptor regulation, by which autophagy modu-
lates the host immune response to mycobacteria as well as
to other pathogens. Further, we show that autophagy is
required for defense against mycobacteria in vivo. The increase
in bacterial internalization in autophagy-deficient mice was
shown both in cultured cells and in vivo. The increased uptake
of bacteria in autophagy-deficient macrophages raises ques-
tions about the relative contribution of increased phagocytosis
and of decreased lysosomal degradation to the enhanced sur-
vival of mycobacteria observed in these cells. The biological
consequences of increased phagocytosis should vary depend-
ing on the type of pathogen and the integrity of other host de-
fense machinery. In autophagy-competent cells, increased
phagocytosis per se should be beneficial to the host to capture
and kill extracellular pathogens. In contrast, in autophagy-defi-
cient cells, increased phagocytosis of intracellular pathogens is
likely to lead to exaggerated infection. The LysM-Cre system
deletes ATG7 from all myeloid cells—not only macrophages
but also monocytes and granulocytes. Our study focused on
macrophages because they are the first cell encountered by
mycobacteria within the respiratory tract, the primary host
cell, and the main effector cell responsible for killing upon acti-
vation. However, the role(s) of granulocytes and monocytes in
this model remain elusive. Although BCG lacks the ESX-1
secretion system important for autophagy induction (Gutierrez
et al., 2004), in contrast to Mtb, we did not observe differences
in the effect of autophagy on internalization between both
species.munity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc. 543
Figure 6. Increased mRNA Expression of
Class A Scavenger Receptors and NFE2L2
Activity in Atg7–/– Macrophages
(A and B) Real-time PCR was done with mRNA of
BMDMs from Atg7/ and Atg7+/+ mice and spe-
cific primers for MARCO (A) or Msr1 (B). Data are
expressed as fold increase, normalized to 18S
mRNA.
(C) Immunoblot analysis was done on nuclear
fraction of the cell lysates with NFE2L2 antibody.
Laminin was used as a loading control.
(D) NFE2L2 activation in nuclear extracts was
measured by quantification of the DNA binding
activity of NFE2L2 by a colorimetric assay.
(E) Expressions of Nqo1 and Gstm1, downstream
gene targets of NFE2L2, and of TFEB andStub1, as
control genes, were analyzed by RT-PCR.
(F) Cell lysates were analyzed by immunoblot with
antibodies against NQO1, LC3, ATG7, or b-ACTIN.
Data are mean ± SD, n = 3, *p < 0.05. See also
Figure S5.
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Autophagy Regulates PhagocytosisMycobacteria are internalized through a broad array of phago-
cytic receptors (Ernst, 1998). We observed that the upregulation
of phagocytosis was associated with increased surface expres-
sion of twophagocytic scavenger receptors,MSR1andMARCO.
Scavenger receptors are transmembraneglycoproteins that bind
to different ligands and induce their uptake and clearance (Are-
schoug and Gordon, 2009). They play a role in innate immunity
as pattern-recognition receptors mediating phagocytosis of
different pathogens. MARCO and MSR1 are well-characterized
class A scavenger receptors with a broad ligand specificity.
They are expressed on macrophages, upregulated upon bacte-
rial infection, and have been implicated in bacterial binding and
removal (Arredouani et al., 2005;Rogers et al., 2009). In the lungs,
these scavenger receptors mediate uptake and clearance of air-
borne pathogens and inhaled environmental particles (Jo´zefow-
ski et al., 2005). Expression of MARCO and MSR1 is increased
in macrophages upon BCG (Ito et al., 1999) and Mtb (Court
et al., 2010) infection, suggesting a role for these scavenger re-
ceptors in antimycobacterial response. However, redundancy
of multiple receptors involved in phagocytosis of mycobacteria
complicates interpretation of experiments in examining the effect
of deficiency of a single cell-surface receptor on Mtb infection
(Court et al., 2010). Supporting the hypothesis that these recep-
tors play a role in host defense against infection, a recent study
showed that genetic variants ofMARCOare associatedwith sus-
ceptibility to tuberculosis in humans (Ma et al., 2011). It has been
shown that mice lackingMARCO andMSR1 have defective bac-
terial clearance and higher proinflammatory responses when
challenged with other bacteria. MARCO and MSR1 also protect
against oxidant particles by downregulating lung inflammation
after inhalation of titaniumdioxide, ozone, silica, or environmental
allergens (Arredouani et al., 2007).544 Immunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc.We conclude that the increase in
phagocytosis observed in ATG7-deficient
macrophages was caused by scavenger
receptor upregulation. The increased sur-
face expression of these receptorsobserved in Atg7/ macrophages was attributed to upregula-
tion of NFE2L2 activity caused by SQSTM1 accumulation. It
was recently shown that higher amounts of SQSTM1 lead to
accumulation of NFE2L2. Indeed, accumulation of SQSTM1 in
liver (Komatsu et al., 2007) or bronchiolar epithelial cells defi-
cient in ATG7 (Inoue et al., 2011) has been shown to result in
NFE2L2 activation and increased expression of detoxifying en-
zymes. Although we have demonstrated that in autophagy-defi-
cient macrophages SQSTM1-mediated activation of NFE2L2
results in transcriptional increase in class A scavenger recep-
tors, we cannot rule out the possibility that changes in other
NFE2L2 target genes contribute to the observed phenotype. It
has recently been shown that increased NFE2L2 can lead to
increased phagocytosis by increased MARCO expression (Har-
vey et al., 2011). It is unlikely that the observed increase in
scavenger receptor expression in Atg7/ macrophages is
caused by alternative activation of these macrophages,
because no differences in mannose receptor or IL-10 and IL-
12 were found.
Phagocytosis and endocytosis are related but quite distinct
cellular processes. Although phagocytosis was increased in
Atg7/ macrophages, endocytosis of particles, known to use
scavenger receptors for cell entry, was not substantially
affected. The ingestion of particles by phagocytosis requires
the formation of large endocytic vacuolar compartments by the
organized movements of membranes and the actin cytoskel-
eton. In contrast to simple endocytosis, phagocytosis requires
the integration of membrane receptors, cytoplasmic proteins
that bind receptors and initiate and amplify signaling, plasma
membrane lipids, and proteins that regulate actin polymerization
and membrane fusion. We hypothesized that changes in other
cellular components might synergize with the increased
Immunity
Autophagy Regulates Phagocytosisscavenger receptor expression to account for the observed in-
crease in phagocytosis.
Collectively, this study reveals that defects in autophagy lead
to increased susceptibility tomycobacterial infection, not only by
impairing themacrophage-killing capacity but also by increasing
the amount of bacteria internalized. Further, it reveals insights
into the regulation of scavenger receptors by autophagy. These
insights increase our understanding of the host-pathogen rela-
tionship and lay the groundwork for strategies aimed at
combating infectious diseases. Understanding the interactions
between phagocytosis and autophagy is fundamental to the
identification of new therapeutic strategy against pathogens




We purchased C57BL/6, p50-deficient, and LysM-Cre transgenic mice from
Jackson Laboratory. Mice genetically deficient for TLR4, TIRAP, or TRIF
were kind gifts from R. Medzhitov and S. Akira, respectively. Atg7flox mice
and SQSTM1-deficient mice were previously described (Komatsu et al.,
2007). Mice were housed within a biosafety level 2 vivarium. Mice were used
at 8–20 weeks of age. This study followed a protocol approved by the animal
care committee of our institution.
Isolation and Culture of Mouse Macrophages
Mice were euthanized by asphyxia in a high CO2 environment. Bone marrow
cells were cultured in DMEM+Glutamax (Gibco) with 10% FBS. Cells were
differentiated into macrophages by using 10 ng/ml mouse M-CSF (Sigma)
for 7 days in 5% CO2 at 37
C. Alveolar macrophages were collected by bron-
choalveolar lavage (BAL) with complete DMEM containing 0.5 mM EDTA
(Sigma). Based on F4/80 expression, more than 95% of BAL cells were mac-
rophages. Peritoneal macrophages were collected by peritoneal lavage via
complete DMEM. Cells were plated on coverslips and after 2 hr incubation
at 37C, and nonadherent cells were removed by gentle washing. Cell mono-
layers were cultured overnight in complete medium. Viability of the collected
cells was consistently >95% by trypan blue exclusion.
PCR and Immunoblot Analysis
Total RNAwas purifiedwith an RNEasyMini Kit (QIAGEN), and cDNA synthesis
was performed with cDNA Reverse Transcription Kit (Applied Biosystems).
Target genes and 18S mRNA expression were measured in 96-well optical
plates by using Taqman Universal PCR Master Mix and the StepOnePlus
Real-Time PCR Systems (Applied Biosystems). For immunoblot analysis, cells
were washed with cold PBS and lysed with RIPA buffer in the presence of a
protease inhibitor cocktail (Beckton Dickinson) for 30 min on ice. Total protein
concentrations were determined with the BCA protein assay kit (Pierce). Cell
lysates (50 mg of protein) were heated at 100C for 5 min in sample buffer,
resolved on SDS-PAGE, and transferred to nitrocellulose membranes. Anti-
bodies to b-ACTIN, ATG7, SQSTM1, LC3, ATG5, NQO1, NFE2L2, MSR1,
and laminin were used. Immunoreactive bands were detected by infrared
imaging system (Odyssey).
Flow Cytometry and Fluorescence Microscopy
Cells were washed in staining buffer (0.5%BSA-PBS) and incubated for 30min
at 4C in the dark with conjugated mouse monoclonal antibodies diluted in
staining buffer. Monoclonal antibodies against CD11a, CD11b, CD11c,
CD14, CD206, CD36, CD16, CD71, TLR2, TLR4, CD40, CD86, CD69,
CD195, CD184, CD119, CD120b, and CD212 were purchased from Becton
Dickinson; MARCO antibody was from Serotec; CD209 antibody was from
eBioscience; and polyclonal MSR1 antibody (AF1797) was fromR&DSystems.
Cells were pretreated with a rat anti-mouse CD16/CD32 (Becton Dickinson) to
block nonspecific binding and isotypes were used as controls. After incuba-
tion, cells were washed twice in staining buffer, labeled with sytox blue forImcell viability, and analyzed immediately. Flow cytometry was performed with
LSR Fortessa (Becton Dickinson), FACSDiva software for data collection,
and FlowJo software for analysis. Cells were first gated based on forward
and scatter properties. Cell duplets were excluded and cells were gated on
F4/80-positive (macrophages) and sytox-blue-negative (viable) events. In the
gated events, both percentages of positivity and MFI for each marker were
assessed and untreated and isotype controls were used to determine cutoffs.
At least 10,000 cells were evaluated to determine surface receptor expression.
Data are presented as mean ± SD of mean fluorescence intensity (MFI).
Mycobacterial Infection in Macrophages
BCG and the H37Rv strain of Mtb were cultured in Middlebrook 7H9 broth me-
dium (Becton Dickinson) and stocks were prepared and stored at 80C. At
the time of infection, bacteria were thawed, vortexed, sonicated, and passed
through a 28G needle 15 times to disrupt bacterial clumps. Cellular mono-
layers were infected for 1 hr at an MOI of 10. Upon infection, extracellular
and surface-bound bacteria were killed by the inclusion of 50 mg/ml gentamy-
cin in culture media. Cells were washed three times with ice-cold PBS and
incubated for 3, 5, and 7 days in fresh complete DMEM. After incubation, cells
were lysed with 0.1% SDS and cell lysates were diluted, plated on 7H11 Mid-
dlebrook agar plates (Becton Dickinson), and incubated at 37C in 5% CO2.
Colony-forming units (CFU) were counted 3–4weeks later and results were ex-
pressed as log10 CFU. The BCG and Mtb strains were kindly provided by D.
McMurray from Texas A&M Health Science Center. Experiments involving
Mtb handling were performed in BSL-3 facility.
In Vivo BCG Infection
Micewere intranasally infectedwith 13 106CFUBCG (fivemice per group, per
time point). For bacterial counts, lungs were homogenized, diluted and plated
in 7H11 Middlebrook agar plates (Becton Dickinson), and incubated at 37C in
5% CO2. CFUs were counted 3–4 weeks later. For histological evaluation,
lungs were inflated with 10% formalin, embedded in paraffin, sectioned,
and stained with hematoxilin-eosin or acid fast staining for evaluation of the in-
flammatory infiltrate and the bacterial loads, respectively. The degree of
inflammation was evaluated by scores from 0 to 3 for the following criteria:
0, no inflammation, occasional inflammatory cells; 1, mild inflammation,
increased number of inflammatory cells; 2, moderate inflammation, confluent
inflammatory cells; 3, extensive inflammation, extended infiltrate; and 4,
severe inflammation, massive infiltration. The percentage of tissue involved
in the inflammatory response was determined by morphometric analysis
with the ImageJ 11.4 software from NIH.
Phagocytosis Assays
Macrophages were infected with GFP-expressing BCG or GFP-expressing
Mtb at an MOI of 10 and then incubated at 37C in a 5% CO2 environment.
After infection, macrophages were washed, extracellular bacteria were
removed by 50 mg/ml gentamycin treatment and PBS washing, and cells
were fixed with 4% formaldehyde. Nuclei were counterstained with 40,6-diami-
dino-2-phenylindole (DAPI) (Invitrogen). Coverslips were mounted onto slides
with Slowfade Gold medium and analyzed on a Zeiss Axiovert 200M fluores-
cence microscope. Phagocytosis was evaluated by counting 300 macro-
phages per well at 633 magnification under oil immersion. Serial sections
were taken with Z-stack spanning to confirm colocalization and images
were deconvolved. Percent of infectedmacrophages was estimated by count-
ing cells containing at least one ingested bacterium. Phagocytic index was
generated by multiplying the percentage of phagocytosis by the mean number
of internalized bacteria per cell. Cells incubated with 1.0 mm yellow-green
polystyrene microbeads or zymosan were used as controls. Cytochalasin D
treatment and 4C incubation were used to prevent phagocytosis. To discrim-
inate between intracellular and extracellular bacteria, 0.08 mg/ml trypan blue
was added to quench extracellular fluorescent signal and serial images were
taken across cells. For flow cytometry evaluation, a specific conjugated
F4/80 antibody (eBioscience) was used to identify the cell type, sytox blue (In-
vitrogen) exclusion was used to determine cell viability, and RFP-expressing
BCG was used to quantify bacterial uptake. Cells were infected at an MOI of
10 and then incubated at 37C in a 5% CO2. After infection, macrophages
were washed, extracellular and surface-bound bacteria were removed, and
cells were fixed with 4% formaldehyde. Flow cytometry was performed asmunity 39, 537–547, September 19, 2013 ª2013 Elsevier Inc. 545
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Autophagy Regulates Phagocytosisdescribed above. In the gated events, phagocytosis percentage andMFI were
assessed and uninfected controls were used to determine cutoffs for phago-
cytosis. Phagocytosis ofS. aureus andE. coliwasmeasured by flow cytometry
with pHrodo-labeled bacteria (Invitrogen). To assess themacrophage ability to
phagocytose bacteria in vivo, mice were challenged intraperitoneally with
GFP-expressing BCG. After 2 hr, peritoneal lavage was collected and cells
were fixed and analyzed by microscopy as described above. Scavenger re-
ceptors functions were inhibited by MARCO neutralizing antibody E31 (Hycult
biotechnology) or the class A scavenger receptor antagonists Fucoidan
(Sigma) or polyinosinic acid (Poly-I) (Sigma).
Endocytosis Assays
Cells were incubated in the presence of different ligands (titanium oxide
[Sigma], Alexa Fluor 488-labeled acetylated LDL, dextran, transferrin, cholera
toxin subunit B, or LPS [Invitrogen]) at 37C for 30 or 60min, washed with PBS,
and assayed for fluorescence. Cells were then washed and treated with acid
wash (50 mM glycine, 150 mM NaCl [pH 2.5]) to remove surface-bound parti-
cles (Lei and Martinez-Moczygemba, 2008).
Statistical Analysis
Parametric statistical calculations were performed with Microsoft Excel and
GraphPad Prism software. Differences between two groups were determined
by Student’s t test for samples with equal variance. Comparisons between
more than two groups were done by ANOVA and the Tukey-Kramer test.
p values <0.05 were considered significant. Data are expressed as means ±
standard deviation of three independent experiments.
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